Rachael E. Rayner

414 total citations
18 papers, 237 citations indexed

About

Rachael E. Rayner is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Rachael E. Rayner has authored 18 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 4 papers in Physiology. Recurrent topics in Rachael E. Rayner's work include Neonatal Respiratory Health Research (7 papers), Cystic Fibrosis Research Advances (5 papers) and Pneumonia and Respiratory Infections (4 papers). Rachael E. Rayner is often cited by papers focused on Neonatal Respiratory Health Research (7 papers), Cystic Fibrosis Research Advances (5 papers) and Pneumonia and Respiratory Infections (4 papers). Rachael E. Rayner collaborates with scholars based in United States, Australia and France. Rachael E. Rayner's co-authors include Estelle Cormet‐Boyaka, Patrudu Makena, G. L. Prasad, Flavia Huygens, Louise M. Hafner, Mark E. Peeples, John Savill, María Alfaro, Sheng‐Wei Chang and Prosper N. Boyaka and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Scientific Reports.

In The Last Decade

Rachael E. Rayner

18 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachael E. Rayner United States 7 117 49 46 35 29 18 237
Per M. Åberg Sweden 5 153 1.3× 72 1.5× 23 0.5× 37 1.1× 36 1.2× 7 293
François Carlier Belgium 9 193 1.6× 81 1.7× 35 0.8× 81 2.3× 29 1.0× 22 348
Elizabeth Kicic‐Starcevich Australia 10 252 2.2× 44 0.9× 84 1.8× 118 3.4× 35 1.2× 22 417
Kelly M. Martinovich Australia 10 256 2.2× 58 1.2× 98 2.1× 117 3.3× 32 1.1× 24 437
Nivenka Jayasekera United Kingdom 8 116 1.0× 64 1.3× 37 0.8× 189 5.4× 34 1.2× 18 372
Masanobu Matsuoka Japan 10 107 0.9× 64 1.3× 35 0.8× 54 1.5× 12 0.4× 19 333
Kevin Looi Australia 11 290 2.5× 47 1.0× 93 2.0× 140 4.0× 39 1.3× 26 465
Damien Adam Canada 11 228 1.9× 89 1.8× 20 0.4× 55 1.6× 46 1.6× 29 382
William J. Kissner United States 7 259 2.2× 83 1.7× 31 0.7× 43 1.2× 20 0.7× 10 337
Samuel Montgomery Australia 7 300 2.6× 70 1.4× 63 1.4× 55 1.6× 13 0.4× 15 395

Countries citing papers authored by Rachael E. Rayner

Since Specialization
Citations

This map shows the geographic impact of Rachael E. Rayner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachael E. Rayner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachael E. Rayner more than expected).

Fields of papers citing papers by Rachael E. Rayner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachael E. Rayner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachael E. Rayner. The network helps show where Rachael E. Rayner may publish in the future.

Co-authorship network of co-authors of Rachael E. Rayner

This figure shows the co-authorship network connecting the top 25 collaborators of Rachael E. Rayner. A scholar is included among the top collaborators of Rachael E. Rayner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachael E. Rayner. Rachael E. Rayner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shrestha, Mahesh, Chandra L. Shrestha, Rachael E. Rayner, et al.. (2025). Secondhand vape exposure regulation of CFTR and immune function in cystic fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 328(3). L324–L333. 1 indexed citations
2.
Rayner, Rachael E., et al.. (2024). Single-stranded DNA with internal base modifications mediates highly efficient knock-in in primary cells using CRISPR-Cas9. Nucleic Acids Research. 52(22). 13561–13576. 3 indexed citations
3.
Rayner, Rachael E., Reza Nouri, Carlos J. Suarez, et al.. (2024). DNA-PKcs inhibition improves sequential gene insertion of the full-length CFTR cDNA in airway stem cells. Molecular Therapy — Nucleic Acids. 35(4). 102339–102339. 2 indexed citations
4.
Rayner, Rachael E., Sun‐Hee Kim, Phylip Chen, et al.. (2023). Architecture and matrix assembly determinants of Bordetella pertussis biofilms on primary human airway epithelium. PLoS Pathogens. 19(2). e1011193–e1011193. 6 indexed citations
5.
Rayner, Rachael E., Daniela Farkas, Rama K. Mallampalli, et al.. (2023). Influenza virus reduces ubiquitin E3 ligase MARCH10 expression to decrease ciliary beat frequency. American Journal of Physiology-Lung Cellular and Molecular Physiology. 324(5). L666–L676. 5 indexed citations
6.
Rayner, Rachael E., Sheng‐Wei Chang, Sun Hee Kim, et al.. (2022). Targeting the EGFR‐ERK axis using the compatible solute ectoine to stabilize CFTR mutant F508del. The FASEB Journal. 36(5). e22270–e22270. 10 indexed citations
7.
8.
Rayner, Rachael E., et al.. (2021). Transcriptomic Response of Primary Human Bronchial Cells to Repeated Exposures of Cigarette and ENDS Preparations. Cell Biochemistry and Biophysics. 80(1). 217–228. 6 indexed citations
9.
Rayner, Rachael E., Patrudu Makena, G. L. Prasad, & Estelle Cormet‐Boyaka. (2020). Cigarette smoke preparations, not electronic nicotine delivery system preparations, induce features of lung disease in a 3D lung repeat-dose model. American Journal of Physiology-Lung Cellular and Molecular Physiology. 320(2). L276–L287. 7 indexed citations
10.
Rayner, Rachael E., et al.. (2020). In vitro 3D culture lung model from expanded primary cystic fibrosis human airway cells. Journal of Cystic Fibrosis. 19(5). 752–761. 13 indexed citations
11.
Hayes, Don, Rachael E. Rayner, Cynthia L. Hill, et al.. (2020). Airway epithelial stem cell chimerism in cystic fibrosis lung transplant recipients. Journal of Cystic Fibrosis. 20(1). 165–172. 10 indexed citations
12.
Rayner, Rachael E., Patrudu Makena, G. L. Prasad, & Estelle Cormet‐Boyaka. (2019). Cigarette and ENDS preparations differentially regulate ion channels and mucociliary clearance in primary normal human bronchial 3D cultures. American Journal of Physiology-Lung Cellular and Molecular Physiology. 317(2). L295–L302. 19 indexed citations
13.
Rayner, Rachael E., Patrudu Makena, G. L. Prasad, & Estelle Cormet‐Boyaka. (2019). Optimization of Normal Human Bronchial Epithelial (NHBE) Cell 3D Cultures for in vitro Lung Model Studies. Scientific Reports. 9(1). 500–500. 126 indexed citations
14.
Chang, Sheng‐Wei, Xiaoli Zhang, Rachael E. Rayner, et al.. (2018). The psychoactive substance of cannabis Δ9-tetrahydrocannabinol (THC) negatively regulates CFTR in airway cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1862(9). 1988–1994. 6 indexed citations
15.
Rayner, Rachael E., John Savill, Louise M. Hafner, & Flavia Huygens. (2015). Genotyping streptococcus pneumoniae. QUT ePrints (Queensland University of Technology). 1 indexed citations
16.
Rayner, Rachael E., John Savill, Louise M. Hafner, & Flavia Huygens. (2015). Modified MLVA for Genotyping Queensland Invasive Streptococcus pneumoniae. PLoS ONE. 10(4). e0121870–e0121870. 2 indexed citations
17.
Rayner, Rachael E., John Savill, Louise M. Hafner, & Flavia Huygens. (2015). Genotyping Streptococcus Pneumoniae. Future Microbiology. 10(4). 653–664. 9 indexed citations
18.
Tee, Wee, et al.. (1992). Use of ribosomal RNA gene restriction patterns to investigate two outbreaks of campylobacter enteritis in Melbourne, Australia. Journal of Medical Microbiology. 37(6). 385–388. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Per M. Åberg Breakdown of academic impact, for papers by François Carlier Breakdown of academic impact, for papers by Elizabeth Kicic‐Starcevich Breakdown of academic impact, for papers by Kelly M. Martinovich Breakdown of academic impact, for papers by Nivenka Jayasekera Breakdown of academic impact, for papers by Masanobu Matsuoka Breakdown of academic impact, for papers by Kevin Looi Breakdown of academic impact, for papers by Damien Adam Breakdown of academic impact, for papers by William J. Kissner Breakdown of academic impact, for papers by Samuel Montgomery
Rankless by CCL
2026